Literature DB >> 26037713

Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.

Tomoki Kobayashi1, Hiroshi Aikata2, Masahiro Hatooka1, Kei Morio1, Reona Morio1, Hiromi Kan1, Hatsue Fujino1, Takayuki Fukuhara1, Keiichi Masaki1, Atsushi Ohno1, Noriaki Naeshiro1, Takashi Nakahara1, Yohji Honda1, Eisuke Murakami1, Tomokazu Kawaoka1, Masataka Tsuge1, Akira Hiramatsu1, Michio Imamura1, Yoshiiku Kawakami1, Hideyuki Hyogo1, Shoichi Takahashi1, Kazuaki Chayama1,3.   

Abstract

OBJECTIVE: Non-simple nodules in hepatocellular carcinoma (HCC) correlate with poor prognosis. Therefore, we examined the diagnostic ability of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (EOB-MRI) and contrast-enhanced ultrasound (CEUS) for diagnosing the macroscopic classification of small HCCs.
METHODS: A total of 85 surgically resected nodules (≤30 mm) were analyzed. HCCs were pathologically classified as simple nodular (SN) and non-SN. By evaluating hepatobiliary phase (HBP) of EOB-MRI and Kupffer phase of CEUS, the diagnostic abilities of both modalities to correctly distinguish between SN and non-SN were compared.
RESULTS: Forty-six nodules were diagnosed as SN and the remaining 39 nodules as non-SN. The area under the ROC curve (AUROCs, 95% confidence interval) for the diagnosis of non-SN were EOB-MRI, 0.786 (0.682-0.890): CEUS, 0.784 (0.679-0.889), in combination, 0.876 (0.792-0.959). The sensitivity, specificity, and accuracy were 64.1%, 95.7%, and 81.2% in EOB-MRI, 56.4%, 97.8%, and 78.8% in CEUS, and 84.6%, 95.7%, and 90.6% in combination, respectively. High diagnostic ability was obtained when diagnosed in both modalities combined. The sensitivity was especially statistically significant compared to CEUS.
CONCLUSION: Combined diagnosis by EOB-MRI and CEUS can provide high-quality imaging assessment for determining non-SN in small HCCs. KEY POINTS: • Non-SN has a higher frequency of MVI and intrahepatic metastasis than SN. • Macroscopic classification is useful to choose the treatment strategy for small HCCs. • Diagnostic ability for macroscopic findings of EOB-MRI and CEUS were statistically equal. • The diagnosis of macroscopic findings by individual modality has limitations. • Combined diagnosis of EOB-MRI and CEUS provides high diagnostic ability.

Entities:  

Keywords:  Combined diagnosis; Contrast-enhanced ultrasound; Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging; Hepatocellular carcinoma; Macroscopic findings

Mesh:

Substances:

Year:  2015        PMID: 26037713     DOI: 10.1007/s00330-015-3725-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  31 in total

1.  Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm.

Authors:  Keiji Mita; Soo Ryang Kim; Masatoshi Kudo; Susumu Imoto; Taisuke Nakajima; Kenji Ando; Katsumi Fukuda; Toshiyuki Matsuoka; Yoko Maekawa; Yoshitake Hayashi
Journal:  World J Gastroenterol       Date:  2010-09-07       Impact factor: 5.742

2.  Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.

Authors:  Kyosuke Yanagisawa; Fuminori Moriyasu; Takeo Miyahara; Miyata Yuki; Hiroko Iijima
Journal:  Ultrasound Med Biol       Date:  2007-02       Impact factor: 2.998

3.  Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.

Authors:  Keiko Korenaga; Masaaki Korenaga; Matakazu Furukawa; Takahiro Yamasaki; Isao Sakaida
Journal:  J Gastroenterol       Date:  2009-04-23       Impact factor: 7.527

4.  Diagnostic accuracy for macroscopic classification of nodular hepatocellular carcinoma: comparison of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and angiography-assisted computed tomography.

Authors:  Toshifumi Tada; Takashi Kumada; Hidenori Toyoda; Takanori Ito; Yasuhiro Sone; Seiji Okuda; Sadanobu Ogawa; Takumi Igura; Yasuharu Imai
Journal:  J Gastroenterol       Date:  2014-02-22       Impact factor: 7.527

5.  Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival.

Authors:  Eric Dupont-Bierre; Philippe Compagnon; Jean-Luc Raoul; Gabriel Fayet; Anne-Sophie de Lajarte-Thirouard; Karim Boudjema
Journal:  J Am Coll Surg       Date:  2005-09-30       Impact factor: 6.113

Review 6.  Measuring the accuracy of diagnostic systems.

Authors:  J A Swets
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

7.  Risk factors and outcome of early recurrence after resection of small hepatocellular carcinomas.

Authors:  Masaki Kaibori; Morihiko Ishizaki; Takamichi Saito; Kosuke Matsui; A-Hon Kwon; Yasuo Kamiyama
Journal:  Am J Surg       Date:  2009-01-29       Impact factor: 2.565

8.  The gross classification of hepatocellular carcinoma: usefulness of contrast-enhanced US.

Authors:  Kinuyo Hatanaka; Yasunori Minami; Masatoshi Kudo; Tatsuo Inoue; Hobyung Chung; Seiji Haji
Journal:  J Clin Ultrasound       Date:  2014-01       Impact factor: 0.910

9.  Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.

Authors:  Shuji Sumie; Ryoko Kuromatsu; Koji Okuda; Eiji Ando; Akio Takata; Nobuyoshi Fukushima; Yasutomo Watanabe; Masamichi Kojiro; Michio Sata
Journal:  Ann Surg Oncol       Date:  2008-03-07       Impact factor: 5.344

10.  Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.

Authors:  Shimul A Shah; Sean P Cleary; Alice C Wei; Ilun Yang; Bryce R Taylor; Alan W Hemming; Bernard Langer; David R Grant; Paul D Greig; Steven Gallinger
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

View more
  3 in total

1.  Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma.

Authors:  Chuang Chen; Hui Zhao; Xu Fu; LuoShun Huang; Min Tang; XiaoPeng Yan; ShiQuan Sun; WenJun Jia; Liang Mao; Jiong Shi; Jun Chen; Jian He; Jin Zhu; YuDong Qiu
Journal:  Oncotarget       Date:  2017-05-02

2.  The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced ultrasound in detecting hepatocellular carcinoma: A meta-analysis.

Authors:  Jiming Wang; Xiaofei Ye; Jiangfa Li; Songqing He
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

Review 3.  Application of Different Imaging Methods in the Early Diagnosis of Primary Hepatic Carcinoma.

Authors:  Xin'ai Wu; Jianbo Li; Cheng Wang; Guojian Zhang; Na Zheng; Xuemei Wang
Journal:  Gastroenterol Res Pract       Date:  2015-12-24       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.